Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianyao Migu Tablets
- Development stage
- Unknown
- Lead developer
- Shanghai Hutchison Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Jianyao Migu Tablets is a Traditional Chinese Medicine (TCM) product developed by Shanghai Hutchison Pharmaceuticals for the treatment of elderly patients with osteoporotic low back pain. The formulation is specifically targeted at patients presenting with the TCM syndrome of kidney deficiency and blood stasis. It is currently being evaluated in Phase II clinical trials in China (e.g., CTR20220215) to assess its safety and efficacy in alleviating pain and potentially improving bone mineral density in the elderly population. As a TCM formulation, it likely utilizes a combination of botanical extracts intended to strengthen the lower back and densify bone structure.
- Brand names
- Jianyao Migu Tablets
- Other names
- Jianyao Migu Pian
Beyond the preview
Go deeper on Jianyao Migu Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jianyao Migu Tablets.